These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2743925)

  • 21. Oxidative metabolism of hexobarbital in human liver: relationship to polymorphic S-mephenytoin 4-hydroxylation.
    Knodell RG; Dubey RK; Wilkinson GR; Guengerich FP
    J Pharmacol Exp Ther; 1988 Jun; 245(3):845-9. PubMed ID: 3385644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats.
    van der Graaff M; Vermeulen NP; Joeres RP; Vlietstra T; Breimer DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):459-65. PubMed ID: 6631725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-related differences in doxapram-induced alteration of drug action in the rat.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):397-400. PubMed ID: 2813960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of vephylline--a new N-substituted theophylline derivative.
    Staneva D; Mihailova D; Astroug H; Prodanova K; Micheva M
    Acta Physiol Pharmacol Bulg; 1988; 14(1):30-4. PubMed ID: 3407413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of phototherapy on the activity of microsomal mixed-function monooxygenases and the pharmacokinetics of [14C] hexobarbital in jaundiced and heterozygous Gunn rats.
    Tabata M; Ostrow JD; Webster CC; Zucker GM; Kapitulnik J
    J Pharmacol Exp Ther; 1986 Mar; 236(3):561-7. PubMed ID: 3950863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of aging on the metabolism of simultaneously administered hexobarbital enantiomers and antipyrine before and after phenobarbital induction in male rats: a longitudinal study.
    Groen K; Breimer DD; Jansen EJ; van Bezooijen CF
    J Pharmacol Exp Ther; 1994 Feb; 268(2):531-6. PubMed ID: 8113964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine.
    Kaul KL; Novak RF
    J Pharmacol Exp Ther; 1987 Oct; 243(1):384-90. PubMed ID: 3668864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450.
    Farrell GC; Gollan JL; Correia MA; Schmid R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):363-7. PubMed ID: 7252836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of substrate binding capacity of the hepatic microsomal cytochrome P-450 in Fasciola hepatica infected rats: toxicological implications.
    Maffei Facino R; Carini M
    Farmaco Sci; 1982 Mar; 37(3):184-91. PubMed ID: 6802668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of perinatal low protein diets on the ontogeny of select hepatic cytochrome p450 enzymes and cytochrome p450 reductase in the rat.
    Cherala G; Shapiro BH; D'mello AP
    Drug Metab Dispos; 2007 Jul; 35(7):1057-63. PubMed ID: 17392395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between cadmium and phenobarbital on the activity of the hepatic microsomal monooxygenase system in the male rat.
    Means JR; Schnell RC
    Res Commun Chem Pathol Pharmacol; 1980 Jan; 27(1):187-90. PubMed ID: 7360999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I and phase II xenobiotic biotransformation in different inbred strains of rats: study in immobilized perfused hepatocytes.
    Hynie S; Kren V; Mráz M; Farghali H
    Folia Biol (Praha); 1998; 44(4):127-32. PubMed ID: 10732701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of model traumatic injury on hepatic drug metabolism in the rat. II. In vivo metabolism of hexobarbital and zoxazolamine.
    Griffeth LK; Rosen GM; Rauckman EJ
    Drug Metab Dispos; 1984; 12(5):582-7. PubMed ID: 6149908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB;
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The hexobarbital sleeping time in a pharmacologico-toxicological experiment with special reference to age and chronobiologically-limited variations in Wistar rat strain WIST/Lppt].
    Lange N; Kühnert M; Ebbinghaus F; Hille G; Wolf U
    Dtsch Tierarztl Wochenschr; 1992 Apr; 99(4):145-8. PubMed ID: 1606896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of hexobarbital metabolism by pyridyl derivatives.
    Varga F; Hankovszky OH; Hideg K; Fischer E; Szily T
    Acta Physiol Acad Sci Hung; 1973; 44(3-4):235-45. PubMed ID: 4807136
    [No Abstract]   [Full Text] [Related]  

  • 38. [The influence of acoustic stimuli on sleep of the white rat under hexobarbital].
    Wagner G; Loertzer HJ
    Z Gesamte Hyg; 1977 May; 23(5):282-4. PubMed ID: 888468
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of pyralgin on pharmacodynamics and kinetics of hexobarbital].
    Mazurek K; Chodera A
    Acta Pol Pharm; 1981; 38(3):363-8. PubMed ID: 7315472
    [No Abstract]   [Full Text] [Related]  

  • 40. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.